Wang Lingke: insider trades.
Wang Lingke reported 11 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 8 sales ($9.3M), across 1 company.
- Transactions
- 11
- Purchases (P)
- 0
- Sales (S)
- 8
- Companies
- 1
- Name as filed
- Wang Lingke
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Ethos Technologies Inc. (LIFE) | Director, Officer · President | 11 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-17 | Ethos Technologies Inc. | S | 110,587 | $39 | 1,537,858 | Form 4 |
| 2026-09-17 | Ethos Technologies Inc. | S | 7,431 | $38.36 | 1,648,445 | Form 4 |
| 2026-09-17 | Ethos Technologies Inc. | S | 315 | $39.67 | 1,537,543 | Form 4 |
| 2026-09-17 | Ethos Technologies Inc. | C | 118,333 | — | 1,655,876 | Form 4 |
| 2026-08-20 | Ethos Technologies Inc. | S | 32,309 | $32.63 | 1,623,567 | Form 4 |
| 2026-08-20 | Ethos Technologies Inc. | S | 6,012 | $33.98 | 1,537,543 | Form 4 |
| 2026-08-20 | Ethos Technologies Inc. | S | 80,012 | $33.51 | 1,543,555 | Form 4 |
| 2026-08-20 | Ethos Technologies Inc. | C | 83,197 | — | 1,655,876 | Form 4 |
| 2026-08-17 | Ethos Technologies Inc. | S | 210 | $34.8 | 1,572,679 | Form 4 |
| 2026-08-17 | Ethos Technologies Inc. | S | 22,413 | $34.28 | 1,572,889 | Form 4 |
| 2026-07-08 | Ethos Technologies Inc. | A | 900,000 | $0 | 1,595,302 | Form 4 |
Questions
What stock did Wang Lingke buy or sell?
Wang Lingke reported 11 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 8 sales ($9.3M), across 1 company.
Is Wang Lingke the same person as other filers with this name?
This page covers SEC CIK 2089263 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/wang-lingke-2089263.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.